Temperature-sensitive mutants of Newcastle disease virus altered in HN glycoprotein size, stability, or antigenic maturity.
It has been suggested that the 11 group B, C, and BC temperature-sensitive (ts) mutants of Newcastle disease virus (NDV), strain Australia-Victoria (AV-WT), have lesions in the gene for the hemagglutinin/neuraminidase glycoprotein (HN), and that complementation between groups B and C is intracistronic. Virions produced by these mutants even at permissive temperature contain greatly reduced amounts of HN, and the accompanying hemagglutinating and neuraminidase functions. To explore the basis for decreased HN incorporation into virions and the temperature sensitivity of these mutants, infected chick embryo cells were examined for changes in HN characteristics. The HN of two of the mutants was clearly altered in electrophoretic migration rates in both virions and infected cells. The migrational differences were not due to differences in glycosylation because altered migration rates were also observed in the presence of tunicamycin. In all cases, cells infected by these mutants produced as much HN as did AV-WT-infected cells, but the HN of six of these mutants was metabolically unstable. All of the mutants, including those with metabolically stable HN, exhibited greatly restricted ability to convert HN to an antigenically reactive form, indicating an early block in processing. For most of these mutants, the neuraminidase activities of infected cells were somewhat temperature sensitive, but the production of hemadsorbing activities on cell surfaces was not temperature sensitive. In contrast, the hemadsorbing and neuraminidase activities of cells infected by one mutant, BC2, were temperature sensitive, probably a reflection of the previously described extreme thermolability of the HN of this mutant. The relationship between these mutant characteristics, their temperature sensitivity and the virion phenotypes, is discussed. The data presented here confirm the assignment of these 11 group B, C, and BC mutants to defects in HN and begin to separate them into groups with different characteristics.
Peeples
M E
ME
Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612.
Glickman
R L
RL
Gallagher
J P
JP
Bratt
M A
MA
D000818:Animals; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology; D002642:Chick Embryo; D006023:Glycoproteins / Q000235:genetics / Q000276:immunology; D015707:HN Protein; D006389:Hemagglutinins, Viral / Q000235:genetics* / Q000276:immunology; D008970:Molecular Weight; D009439:Neuraminidase / Q000235:genetics* / Q000276:immunology; D009522:Newcastle disease virus / Q000235:genetics* / Q000276:immunology; D013696:Temperature; D014759:Viral Envelope Proteins / Q000235:genetics* / Q000276:immunology
D000956:Antigens, Viral; D006023:Glycoproteins; D015707:HN Protein; D006389:Hemagglutinins, Viral; D014759:Viral Envelope Proteins; D009439:Neuraminidase